Given the role of CREB1 in regulating CENPE, therapies that disrupt the CREB1‐CENPE axis may be particularly effective in inhibiting tumour growth and metastasis in ccRCC patients. This evidence concerns the gene CREB1 and nonpapillary renal cell carcinoma.